WHO WE ARE
A trusted partner in the development and manufacture of niche generic finished dose products for the US Market.
Aggrega Pharma is a specialty generic pharmaceutical company focused on developing, manufacturing and marketing niche, complex, high-barrier-to-entry generic medications (injectable, ophthalmic, ER/IR oral, transdermal, spray, and topical finished dosage forms) for the US Market. The shareholders are 4 European companies: Bluepharma (Portugal), Rafarm (Greece), Substipharm (France) and Welding (Germany). Aggrega Pharma is committed to building a selective, valuable pipeline of generic products by leveraging the vast R&D, clinical and manufacturing experience and capabilities of its members.
Global Product Launches